Welcome to our dedicated page for CARLISLE COMPANIES SEC filings (Ticker: CSL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Carlisle Companies Incorporated filings document the regulatory record for an NYSE-listed building envelope products company with common stock trading under CSL. Form 8-K reports furnish quarterly operating results and disclose material events such as officer and director changes, compensation arrangements, share repurchase authorization, and completed public debt offerings.
The company’s proxy materials address board governance, shareholder voting matters, and executive compensation. Debt-related filings describe senior unsecured notes, including the 2035 and 2040 maturities, while securities disclosures identify Carlisle’s common stock and capital-structure terms.
Frias James D reported acquisition or exercise transactions in this Form 4 filing.
Carlisle Companies Inc. director James D. Frias received a grant of 505 shares of Common Stock as restricted shares from the issuer for his services as a director. These were awarded at a stated price of $0.0000 per share and increased his directly owned holdings to 5,526 shares.
Carlisle Companies reported Q1 2026 revenue of $1.05 billion, down 4% from $1.10 billion as harsh winter weather and softer non-residential construction reduced volumes. Operating margin improved to 17.1% from 16.8%, and income from continuing operations was $127.7 million versus $140.1 million.
Diluted EPS from continuing operations was $3.10, nearly flat with $3.13, while adjusted EBITDA was $234.6 million with a 22.3% margin, up from 21.8%. Cash fell to $771.3 million, largely due to a $125 million tax-related payment and $250 million of share repurchases plus $45.7 million in dividends.
Carlisle Companies reported first quarter 2026 revenue of $1.05 billion, down 4% from 2025, as winter weather and softer new construction weighed on volumes. Operating margin improved to 17.1%, while diluted EPS was $3.10, slightly below $3.13 a year ago.
Adjusted results were steadier: adjusted EBITDA was $234.6 million with a 22.3% margin, up 50 basis points, and adjusted EPS rose to $3.63. CCM grew adjusted EBITDA margin to 27.4% despite a 5% revenue decline, while CWT’s adjusted EBITDA margin eased to 15.2%. The company used $45 million in operating cash, largely due to a $125 million tax-related settlement, and generated negative free cash flow of $73 million.
Carlisle repurchased $250 million of stock and paid $46 million in dividends, ending the quarter with $771 million in cash and $2.89 billion of long-term debt. Management reaffirmed 2026 guidance for low-single-digit revenue growth and about 50 basis points of adjusted EBITDA margin expansion.
The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A reporting 0 shares beneficially owned in Carlisle Cos Inc common stock. The filing explains an internal realignment on January 12, 2026 that disaggregated certain subsidiaries, which now report holdings separately. The amendment is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.
Carlisle Companies Incorporated has released its 2026 proxy statement for the annual meeting on April 29, 2026 at The St. Regis Longboat Key Resort in Florida. Stockholders will vote on electing two directors, approving 2025 named executive officer pay on an advisory basis, and ratifying the independent auditor.
The proxy outlines a majority-vote, classified board with a strong independence focus, use of a Lead Independent Director, and active board committees overseeing audit, compensation, and governance. It details a pay-for-performance program tied to Vision 2030, with executive incentives based on 2025 sales of $4.991 billion, earnings of $759 million, and a 20.5% operating margin, as well as rigorous stock ownership and anti-hedging policies.
Carlisle Companies director Sheryl Palmer reported acquiring 1 deferred stock unit as a grant tied to the company’s quarterly dividend. Each deferred stock unit is economically equivalent to one share of Carlisle common stock and will be settled in cash when her service as a director ends.
Payment will be made either in a lump sum or in quarterly installments over ten years, based on the closing price of Carlisle’s common stock on each payment date. This filing reflects routine director compensation rather than an open-market stock purchase or sale.
Collins Jonathan R. reported acquisition or exercise transactions in this Form 4 filing.
Carlisle Companies director Jonathan R. Collins received a grant of 16 restricted stock units tied to the company’s quarterly dividend. Each unit represents one share of common stock, bringing his directly held restricted stock units to 5,902. The units were fully vested at grant, with shares to be delivered when his board service ends.
Frias James D reported acquisition or exercise transactions in this Form 4 filing.
Carlisle Companies director James D. Frias reported receiving an additional award of 24 restricted stock units. These units were credited as a result of a quarterly dividend declared and paid by the company, and each unit represents the right to receive one share of common stock.
The restricted stock units were fully vested on the grant date, and delivery of the underlying shares will occur when Frias’s service as a director ends. Following this grant, he directly holds 8,643 restricted stock units.
Carlisle Companies director Maia Hansen reported an acquisition of additional restricted stock units tied to the company’s quarterly dividend. The filing shows a grant of 1 restricted stock unit, bringing her directly owned total to 333 units. These units were fully vested at grant, and the underlying shares will be delivered after her service as a director ends.